Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

被引：0
|
作者：
E. L. L. M. De Schryver
J. van Gijn
L. J. Kappelle
P. J. Koudstaal
A. Algra
机构：
[1] University Medical Centre,Dept. of Neurology
[2] University Medical Centre Utrecht H.02.128,Dept. of Neurology
[3] Erasmus Medical Centre,Julius Centre for Health Sciences and Primary Care
[4] University Medical Centre,undefined
来源：
Journal of Neurology | 2005年 / 252卷
关键词：
adherence; stroke; prevention; secondary; compliance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1316 / 1321
页数：5
相关论文
共 50 条
  • [41] Aspirin dose in secondary prevention of stroke
    Diener, HC
    CEREBROVASCULAR DISEASES, 1998, 8 (06) : 360 - 360
  • [42] Aspirin resistance in secondary stroke prevention
    Berrouschot, J
    Schwetlick, B
    von Twickel, G
    Fischer, C
    Uhlemann, H
    Siegemund, T
    Siegemund, A
    Roessler, A
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (01): : 31 - 35
  • [43] Secondary prevention of ischaemic strokes: Effect of dosage of aspirin
    AlvarezSabin, J
    Calvo, G
    Morros, R
    REVISTA DE NEUROLOGIA, 1997, 25 (140) : 541 - 544
  • [44] Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines
    Gronemann, Christian
    Hause, Stephan
    Assmann, Anne
    Neumann, Jens
    Schreiber, Stefanie
    Heinze, Hans-Jochen
    Goertler, Michael
    CEREBROVASCULAR DISEASES, 2020, 49 (04) : 412 - 418
  • [45] Adherence to secondary prevention medication early after acute stroke
    Al AlShaikh, S. A.
    Dawson, J.
    Walters, M.
    Fulton, R.
    Bath, P.
    Shuaib, A.
    CEREBROVASCULAR DISEASES, 2014, 37 : 432 - 432
  • [46] PREVENTION OF GRAFT OCCLUSION BY ASPIRIN, DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS
    LOELIGER, EA
    LANCET, 1993, 342 (8874): : 806 - 806
  • [47] Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    Potpara, Tatjana S.
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1404 - 1406
  • [48] Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox®/Asasantin®) in France
    Marissal, JP
    Selke, B
    Amarenco, P
    PHARMACOECONOMICS, 2004, 22 (10) : 661 - 670
  • [49] Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox®/Asasantin®) in France
    Jean-Pierre Marissal
    Bernard Selke
    PharmacoEconomics, 2004, 22 : 661 - 670
  • [50] A CONTROLLED COMPARISON OF ASPIRIN AND ORAL ANTICOAGULANTS IN PREVENTION OF DEATH AFTER MYOCARDIAL-INFARCTION
    BOISSEL, JP
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (12): : 701 - 708
12345